Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Drug Spending By Some Insurers Hindered By Antitrust Law

This article was originally published in The Tan Sheet

Executive Summary

Statutory caps on nonprescription drug spending by not-for-profit insurers could pose a significant barrier to expanded use of over-the-counter products
Advertisement

Related Content

Pharmacy “Fee-For-Service” Model Could Aid Chronic-Use OTC Switches
Pravachol OTC Label Studies, Redefined Population Urged By Cmte.
Pravachol OTC Label Studies, Redefined Population Urged By Cmte.

Topics

Advertisement
UsernamePublicRestriction

Register

PS096645

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel